海南矿业股份有限公司董事会关于重大资产重组交易的详细说明
一、交易概述
海南矿业股份有限公司（以下简称“公司”）近日发布公告，拟通过发行股份及支付现金的方式，向王中喜、王琛及上海柏帝投资管理有限公司（统称“交易对方”）购买其合计持有的洛阳丰瑞氟业有限公司（以下简称“丰瑞氟业”）69.90%股权。同时，公司计划向不超过35名特定投资者发行股份以募集配套资金。此次交易属于重大资产重组，已按照《上市公司监管指引第9号——上市公司筹划和实施重大资产重组的监管要求》第四条的规定进行说明。
二、交易关键点及投资者关注事项
- 标的资产情况： 本次交易的核心资产为丰瑞氟业69.90%股权。该资产不涉及立项、环保、行业准入、用地、规划、建设施工等报批事项，降低了相关政策及审批风险。
- 审批与风险提示： 公司已在《发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（草案）》中详细披露了本次交易所需履行及尚需报批的程序，并对报批事项可能无法获得批准的风险进行了特别提示。投资者需关注相关审批进展及其可能带来的不确定性。
- 股权合规性： 标的资产不存在出资不实或影响其合法存续的情况。在法律程序和先决条件满足的前提下，股权过户或转让不存在限制或禁止转让的情形，降低了交易法律合规风险。
- 资产完整性及独立性： 交易有助于提升公司的资产完整性，包括获得生产经营所需的商标权、专利权、非专利技术、采矿权、特许经营权等无形资产，有利于公司在人员、采购、生产、销售、知识产权等各方面保持独立性与竞争力。
- 对公司经营的影响： 此次收购预计将增强公司的持续经营能力，不会导致财务状况出现重大不利变化，有助于突出主业、增强抗风险能力及公司独立性。同时，公司强调不会新增重大不利影响的同业竞争，也不会出现严重影响独立性或显失公平的关联交易，进一步保障了中小股东利益。
三、潜在股价影响因素
- 战略意义： 此次收购丰瑞氟业控股权，将显著提升公司在氟化工产业链的布局和市场竞争力，可能带来业绩增长预期和估值提升，属于可能推动公司股价波动的重要事项。
- 资金募集安排： 通过向不超过35名特定投资者发行股份募集配套资金，有助于优化公司资本结构，保障本次重大资产重组顺利实施。
- 审批风险： 由于部分报批程序尚未完成，相关不确定性可能对交易最终落地及公司股价形成影响，投资者需持续关注后续进展公告。
四、总结
此次海南矿业拟通过发行股份及现金收购丰瑞氟业69.90%股权，并配套募集资金，交易完成后有望优化公司产业链结构，增强主业竞争力和持续盈利能力。由于涉及重大资产重组，交易进展及审批结果可能对公司股价产生显著影响，投资者需密切关注相关公告与监管动向。
免责声明：本文内容基于公司公开披露信息，旨在为投资者提供参考，不构成任何投资建议。投资有风险，请审慎决策。
Hainan Mining Co., Ltd. Board of Directors’ Detailed Explanation on Major Asset Restructuring Transaction
1. Transaction Overview
Hainan Mining Co., Ltd. (“the Company”) announced that it intends to acquire a 69.90% equity stake in Luoyang Fengrui Fluorine Industry Co., Ltd. (“Fengrui Fluorine Industry”) from three counterparties—Wang Zhongxi, Wang Chen, and Shanghai Bodhi Investment Management Co., Ltd.—via a combination of share issuance and cash payment. Simultaneously, the Company plans to issue shares to no more than 35 selected investors to raise matching funds. This transaction constitutes a major asset restructuring and has been explained in accordance with Article 4 of the “Supervisory Guidelines No. 9 for Listed Companies—Regulatory Requirements for the Planning and Implementation of Major Asset Restructuring by Listed Companies.”
2. Key Points and Investor Considerations
- Target Asset: The main asset in this transaction is a 69.90% stake in Fengrui Fluorine Industry. The acquisition does not involve project approval, environmental protection, industry access, land use, planning, construction, or other related filings, which reduces policy and approval risks.
- Approval and Risk Disclosure: The Company has detailed the procedures already completed and those pending in the draft report, and has specifically highlighted the risk that certain approvals may not be obtained. Investors should closely monitor the progress of these approvals and the associated uncertainties.
- Equity Compliance: There are no issues with invalid capital contributions or legality of the target asset. Provided legal procedures and prerequisites are met, there are no restrictions or prohibitions on the transfer of the equity, minimizing legal and compliance risks.
- Asset Integrity and Independence: The transaction is expected to enhance the Company’s asset integrity, including acquiring necessary trademarks, patents, non-patented technologies, mining rights, and franchise rights, which will help maintain operational independence and competitiveness in areas such as personnel, procurement, production, sales, and IP.
- Impact on Operations: The acquisition is expected to strengthen the Company’s ability to continue as a going concern and will not result in material adverse changes to its financial position. It will help sharpen the core business, boost risk resistance, and ensure independence. The Company further emphasizes that the transaction will not introduce significant adverse competition, nor will it result in unfair related-party transactions, safeguarding minority shareholders’ interests.
3. Potential Share Price Impact
- Strategic Significance: Acquiring control of Fengrui Fluorine Industry will enhance the Company’s presence in the fluorine chemical industry chain and market competitiveness, potentially driving earnings growth and valuation uplift—key factors that could move the share price.
- Funding Arrangement: The proposed private placement to raise matching funds will optimize the Company’s capital structure and facilitate the completion of this major asset restructuring.
- Approval Risks: As some approval procedures are still pending, related uncertainties could impact the finalization of the transaction and consequently affect the Company’s share price. Investors should closely monitor further announcements.
4. Conclusion
Hainan Mining’s plan to acquire a 69.90% stake in Fengrui Fluorine Industry via a combination of share issuance and cash payment, along with a supporting fundraising round, is likely to optimize the Company’s industrial chain and strengthen its core business and sustainable profitability. As this is a major asset restructuring, transaction progress and regulatory approval results could significantly impact the Company’s share price. Investors are advised to closely follow subsequent disclosures and regulatory developments.
Disclaimer: This article is based on publicly disclosed company information and is intended for investor reference only. It does not constitute investment advice. Investment involves risk. Please make decisions prudently.
